Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 4, 2003
Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapyNorman Moullan, David G Cox, Sandra Angèle, et al.
Nucleic Acids Research|October 17, 2017
PARP2 controls double-strand break repair pathway choice by limiting 53BP1 accumulation at DNA damage sites and promoting end-resectionAlexis Fouquin, Josée Guirouilh-Barbat, Bernard Lopez, et al.
The Journal of Dairy Research|September 27, 2005
Ataxia-telangiectasia genes and breast cancer risk in a French family studyNadine Andrieu, Eve Cavaciuti, Anthony Laugé, et al.
International Journal of Cancer|January 13, 2005
Single-cell analysis of loss of heterozygosity at the ATM gene locus in Hodgkin and Reed-Sternberg cells of Hodgkin's lymphoma: ATM loss of heterozygosity is a rare eventVirginie Lespinet, Fanny Terraz, Christian Recher, et al.
Human Molecular Genetics|December 3, 2004
Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorderMarie Fernet, Moez Gribaa, Mustafa A M Salih, et al.
Cancer Research|April 9, 2009
Oxidation status of human OGG1-S326C polymorphic variant determines cellular DNA repair capacityAnne Bravard, Monique Vacher, Eva Moritz, et al.
Investigative Ophthalmology & Visual Science|July 29, 2003
Idiopathic and radiation-induced ocular telangiectasia: the involvement of the ATM geneMartine Mauget-Faÿsse, Michèle Vuillaume, Maddalena Quaranta, et al.
International Journal of Cancer|June 6, 2013
Variations in the mRNA expression of poly(ADP-ribose) polymerases, poly(ADP-ribose) glycohydrolase and ADP-ribosylhydrolase 3 in breast tumors and impact on clinical outcomeIvan Bieche, Vincent Pennaneach, Keltouma Driouch, et al.
Mutation Research|July 9, 2013
The impact of single-nucleotide polymorphisms (SNPs) in OGG1 and XPC on the age at onset of Huntington diseaseFrédérique Berger, Laurence Vaslin, Lisa Belin, et al.
BMC Cancer|August 21, 2014
PARP inhibition and the radiosensitizing effects of the PARP inhibitor ABT-888 in in vitro hepatocellular carcinoma modelsClément Guillot, Vincent Favaudon, Zdenko Herceg, et al.
Pageof 8